Form 4: Moderna President Sells Shares
Insider Transaction (Form 4)
Stephen Hoge, President of Moderna, Inc., sold 80,575 shares of common stock on September 14, 2026.
Summary
- Option exercise/conversion: acquired 76,453 Common Stock at $12.21 ($933,491) on September 14, 2026; holds 1,566,152 after (Direct).
- Open-market sale: disposed of 40,294 Common Stock at $144.13 ($5,807,574) on September 14, 2026; holds 1,525,858 after (Direct).
- Option exercise/conversion: acquired 76,452 Common Stock at $12.21 ($933,479) on September 15, 2026; holds 1,602,310 after (Direct).
- Open-market sale: disposed of 40,281 Common Stock at $146.07 ($5,883,846) on September 15, 2026; holds 1,562,029 after (Direct).
- Option exercise/conversion: disposed of 76,453 Stock Option (Right to Buy) on September 14, 2026; holds 382,262 after (Direct).
- Option exercise/conversion: disposed of 76,452 Stock Option (Right to Buy) on September 15, 2026; holds 305,810 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $11,691,420 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Stephen Hoge — Officer (President)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Option exercise/conversion | Common Stock | 76,453 | $12 | $933.5K | 1,566,152 |
| 2026-09-14 | Open-market sale | Common Stock | 40,294 | $144 | $5.8M | 1,525,858 |
| 2026-09-15 | Option exercise/conversion | Common Stock | 76,452 | $12 | $933.5K | 1,602,310 |
| 2026-09-15 | Open-market sale | Common Stock | 40,281 | $146 | $5.9M | 1,562,029 |
| 2026-09-14 | Option exercise/conversion | Stock Option (Right to Buy) | 76,453 | — | — | 382,262 |
| 2026-09-15 | Option exercise/conversion | Stock Option (Right to Buy) | 76,452 | — | — | 305,810 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Option exercise/conversion (76,453 shares) |
| 2026-09-14 | Open-market sale (40,294 shares) |
| 2026-09-15 | Option exercise/conversion (76,452 shares) |
| 2026-09-15 | Open-market sale (40,281 shares) |
| 2026-09-14 | Option exercise/conversion (76,453 shares) |
| 2026-09-15 | Option exercise/conversion (76,452 shares) |
Keywords
insider transaction, Form 4, MRNA, Moderna, Inc., bearish, Stephen Hoge
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.